Publications by authors named "Michael Low"

Claim this Profile
R
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins.
Jia-Nan Gong, Tirta M Djajawi, Donia M Moujalled, Giovanna Pomilio, Tiffany Khong, Michael S Low

Cell Death Differ· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach.
Aditya Tedjaseputra, Amanda Tey, Anastasios Nalpantidis, George Grigoriadis, Shaun Fleming, Michael Sze Yuan Low

Intern Med J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilateral adrenal hemorrhage in a postpartum woman with multiple thromboemboli: A case report.
Anna Yi Nan Jiang, Joshua Haron Abasszade, Timothy Abrahams, Kirollos Nan, Michael Sze Yuan Low

J Med Case Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Day-21 bone marrow findings incorrectly designate residual leukaemia in FLT3-mutated acute myeloid leukaemia treated with intensive induction plus midostaurin: a morphology-focused study.
Aditya Tedjaseputra, Sukanya Roy, Kay Htun, Danielle Oh, Zoe McQuilten, Michael Sze Yuan Low

Pathology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indolent T Cell Lymphoproliferation of the Gastrointestinal Tract: An Evolving Disease Entity.
Luke Wang, Elaine Koh, Beena Kumar, Michael S Y Low

Hematol Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FFT-Based Simultaneous Calculations of Very Long Signal Multi-Resolution Spectra for Ultra-Wideband Digital Radio Frequency Receiver and Other Digital Sensor Applications.
Chen Wu, Michael Low

Sensors (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study.
Meletios Athanasios Dimopoulos, Vania T M Hungria, Atanas Radinoff, Sosana Delimpasi, Gabor Mikala, Michael Low

Lancet Haematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of t(11;14) in multiple myeloma: A real-world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related Diseases Registry (MRDR).
Kenneth Jc Lim, Cameron Wellard, Dipti Talaulikar, Joanne Lc Tan, Joanna Loh, Michael Sy Low

EJHaem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2.
Briony Shaw, Jake Shortt, Michael Low, Benjamin Rogers, Zane Kaplan

Intern Med J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombocytopenia, splenomegaly, and periportal fibrosis in a migrant.
Timothy Phan, Michael Sze Yuan Low, Keat Low, Michael Braude

Ann Hematol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two cases of refractory IgG4-related disease successfully treated with tocilizumab.
Jeremy Ong, Susan Brown, Michael Gilbertson, George Grigoriadis, Ian Simpson, Michael Low

Ann Hematol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant diagnosis of chronic myeloid leukaemia and myeloma.
Wenye Looi, Ahmad Zargari, Karen Dun, George Grigoriadis, Pasquale Fedele, Michael Sze Yuan Low

Pathology· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 unmasks the critical role of primary healthcare providers in the timely diagnosis of multiple myeloma.
Adrian Chee, Michael S Y Low, Shahla Vilcassim, George Grigoriadis, Pasquale L Fedele

Intern Med J· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare presentation of myeloma with diffuse osteosclerotic lesions without features of POEMS.
Winston Zheng, Michael Sze Yuan Low

Ann Hematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infiltration of bone marrow space with chondromas mimicking progression of polycythemia vera.
Paul Bao Duy La, Michael Sze Yuan Low

Blood· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excellent outcomes of transformed lymphomas in the rituximab era without autologous stem cell transplantation: an Australian single-centre experience.
Aditya Tedjaseputra, Michael Gilbertson, Michael Low, Pasquale L Fedele, Beena Kumar

Intern Med J· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare case of diffuse large B-cell lymphoma presenting with central pontine myelinolysis.
Phillip Cuong Nguyen, Megan Dunstan, Beena Kumar, Michael Sze Yuan Low

BMJ Case Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival.
Pasquale L Fedele, Yang Liao, Jia-Nan Gong, Yuan Yao, Mark F van Delft, Michael S Y Low

Leukemia· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Therapies for Multiple Myeloma.
Christopher Chang-Yew Leow, Michael Sze Yuan Low

J Pers Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spheroacanthocytes secondary to novel tyrosine kinase inhibitors.
Michael Ashby, Michael Sze Yuan Low

EJHaem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep profiling of apoptotic pathways with mass cytometry identifies a synergistic drug combination for killing myeloma cells.
Charis E Teh, Jia-Nan Gong, David Segal, Tania Tan, Cassandra J Vandenberg, Michael S Y Low

Cell Death Differ· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Erg-driven transcriptional program controls B cell lymphopoiesis.
Ashley P Ng, Hannah D Coughlan, Soroor Hediyeh-Zadeh, Kira Behrens, Timothy M Johanson, Michael Sze Yuan Low

Nat Commun· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adrenal failure secondary to bilateral adrenal haemorrhage in heparin-induced thrombocytopenia.
Aditya Tedjaseputra, Matthew Sawyer, Andy Lim, Julian Grabek, Michael Sze Yuan Low

Ann Hematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IRF4 Activity Is Required in Established Plasma Cells to Regulate Gene Transcription and Mitochondrial Homeostasis.
Michael Sze Yuan Low, Erica J Brodie, Pasquale L Fedele, Yang Liao, George Grigoriadis

Cell Rep· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pitfalls of immunotherapy: lessons from a patient with CTLA-4 haploinsufficiency.
Leisa Rebecca Watson, Charlotte A Slade, Samar Ojaimi, Sara Barnes, Pasquale Fedele, Michael Sze Yuan Low

Allergy Asthma Clin Immunol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis